The Business Times
business-time-50
SUBSCRIBERS

Bayer Pharma continues to boost its presence in the Asia-Pacific

2015 regional revenue rises 7% to 4b euros; clinical trials triple in 9 years

google-preferred-sourceAdd BT as a preferred source
Nisha Ramchandani

Nisha Ramchandani

Published Fri, Mar 18, 2016 · 09:50 PM

    Singapore

    The number of clinical trials conducted by Bayer Pharmaceuticals in Asia Pacific has more than tripled since 2007 - from 21 to 68 - as the healthcare group strengthens its focus on the region.

    Here in Singapore, the number of trials has expanded nearly fourfold to 22 from six in the same time frame.

    TRENDING NOW

    Beijing has said that the measures are designed to clean up the capital market and steer investors towards regulated channels for overseas investment.

    China traders rush for exit after cross-border flow crackdown

    In Malaysia, energy subsidies remain a key challenge for government finances. Yet any reform or reduction must be balanced against rising living costs.

    Growth and stability in the storm: steering Asean economies together

    KSL's Khoo Lee Feng says it is "not so much what you study, but how you learn".

    Johor property old hand KSL readies family handover amid market boom

    US President Donald Trump with President Xi Jinping after a visit to Zhongnanhai Garden in Beijing, on May 15.

    Xi Jinping has just rewritten the rules of US-China rivalry

    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More